Given the potential pharmacological use of calcitriol for therapeutic purposes in breast cancer patients, herein we thought of importance to investigate the regulatory actions of this hormone upon CAMP gene expression under in vitro and in vivo conditions using different phenotypes of breast cancer cells. The gene discussed is CAMP; the disease is breast carcinoma.